Bai Yanan, Lu Yunxing, Wang Kun, Cheng Zule, Qu Youlan, Qiu Shihui, Zhou Lin, Wu Zhenhua, Liu Huiying, Zhao Jianlong, Mao Hongju
State Key Laboratory of Transducer Technology, Shanghai Institute of Microsystem and Information Technology, Chinese Academy of Sciences, Shanghai, 200050, People's Republic of China.
Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049, People's Republic of China.
Nanomicro Lett. 2019 Jul 16;11(1):59. doi: 10.1007/s40820-019-0285-x.
Tumor-derived exosomes are actively involved in cancer progression and metastasis and have emerged as a promising marker for cancer diagnosis in liquid biopsy. Because of their nanoscale size, complex biogenesis, and methodological limitations related to exosome isolation and detection, advancements in their analysis remain slow. Microfluidic technology offers a better analytic approach compared with conventional methods. Here, we developed a bead-based microarray for exosome isolation and multiplexed tumor marker detection. Using this method, exosomes are isolated by binding to antibodies on the bead surface, and tumor markers on the exosomes are detected through quantum dot (QD) probes. The beads are then uniformly trapped and queued among micropillars in the chip. This design benefits fluorescence observation by dispersing the signals into every single bead, thereby avoiding optical interference and enabling more accurate test results. We analyzed exosomes in the cell culture supernatant of lung cancer and endothelial cell lines, and different lung cancer markers labeled with three QD probes were used to conduct multiplexed detection of exosome surface protein markers. Lung cancer-derived samples showed much higher (~ sixfold-tenfold) fluorescence intensity than endothelial cell samples, and different types of lung cancer samples showed distinctive marker expression levels. Additionally, using the chip to detect clinical plasma samples from cancer patients showed good diagnostic power and revealed a well consistency with conventional tests for serological markers. These results provide insight into a promising method for exosome tumor marker detection and early-stage cancer diagnosis.
肿瘤来源的外泌体积极参与癌症进展和转移,并已成为液体活检中癌症诊断的一个有前景的标志物。由于其纳米级尺寸、复杂的生物发生过程以及与外泌体分离和检测相关的方法学限制,其分析进展仍然缓慢。与传统方法相比,微流控技术提供了一种更好的分析方法。在此,我们开发了一种基于珠子的微阵列用于外泌体分离和多重肿瘤标志物检测。使用这种方法,外泌体通过与珠子表面的抗体结合而被分离,外泌体上的肿瘤标志物通过量子点(QD)探针进行检测。然后珠子被均匀地捕获并排列在芯片中的微柱之间。这种设计通过将信号分散到每个珠子中有利于荧光观察,从而避免光学干扰并获得更准确的测试结果。我们分析了肺癌和内皮细胞系的细胞培养上清液中的外泌体,并使用三种QD探针标记的不同肺癌标志物对外泌体表面蛋白标志物进行多重检测。肺癌来源的样本显示出比内皮细胞样本高得多(约六倍至十倍)的荧光强度,并且不同类型的肺癌样本显示出独特的标志物表达水平。此外,使用该芯片检测癌症患者的临床血浆样本显示出良好的诊断能力,并且与血清学标志物的传统检测显示出良好的一致性。这些结果为外泌体肿瘤标志物检测和早期癌症诊断的一种有前景的方法提供了见解。